Isofol Medical
2008
FOUNDED
PUBLIC
STATUS
11-20
EMPLOYEES
ISOFOL
STOCK SYMBOL
1
INVESTMENTS
$2.10
SHARE PRICE
(As of Thursday Closing)
Description
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. It's products used for increase efficacy and reduce the side effects of antimetabolite cancer treatment.
Primary Industry
Hospitals/Inpatient Services
Other Industries
Biotechnology
Other Healthcare Services
Stock Exchange
STO
Primary Office
- Biotech Center
- Arvid Wallgrens Backe 20
- 413 46 Gothenburg
- Sweden
+46 070-764 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Isofol Medical’s full profile, request a free trial.
Isofol Medical Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $2.00 - $3.30 | $67.3M | $2.09 | -$0.44 | 24.4K | 32.1M |
Isofol Medical Financials Summary
|
In Thousands,
USD |
TTM
30-Sep-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 46,133 | 60,165 | 37,827 | |
| Revenue | 0 | 0 | 1 | 59 |
| EBITDA | (14,243) | (9,462) | (8,409) | (7,564) |
| Net Income | (14,240) | (9,553) | (8,428) | (7,580) |
| Total Assets | 21,217 | 32,101 | 44,130 | 2,513 |
| Total Debt | 287 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Isofol Medical Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 01-Jan-2010 | 00000 0000000 | Drug Discovery |
Isofol Medical Executive Team (5)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Bengt Gustavsson | Co-Founder | ||
| Karin Ganlöv | Senior Medical Director | ||
| Roger Tell | Chief Medical Officer | ||
| Jarl Jungnelius Ph.D | Chief Executive Officer |
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »